Resolution Pharmaceuticals Inc.
18Patents
0Active
18Granted
29Portfolio score
Filing activity: Dec 22, 1993 → Dec 24, 1997
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5837218A | Non-receptor cell mediated imaging agents | Human Necessities | 95 | Expired |
| US5659041A | Hydrazino-type radionuclide chelators having an N.sub.3 S configuration | Human Necessities | 61 | Expired |
| US5662885A | Peptide derived radionuclide chelators | Emerging Cross-Sectional Technologies | 42 | Expired |
| US5976495A | Peptide derived radionuclide chelators | Emerging Cross-Sectional Technologies | 29 | Expired |
| US5780006A | Peptide derived radionuclide chelators | Emerging Cross-Sectional Technologies | 29 | Expired |
| US5480970A | Metal chelators | Human Necessities | 26 | Expired |
| US6017511A | Glycopeptide-chelator conjugates | Human Necessities | 19 | Expired |
| US5569745A | Peptide-Chelator conjugates | Human Necessities | 17 | Expired |
| US5688489A | Non-receptor mediated imaging agents | Human Necessities | 10 | Expired |
| US5789555A | Immobilized labelling method | Human Necessities | 9 | Expired |
| US5574140A | Hydrazino-type N.sub.2 S.sub.2 chelators | Emerging Cross-Sectional Technologies | 7 | Expired |
| US5679642A | Peptide-chelator conjugates | Human Necessities | 6 | Expired |
| US5976497A | Dopamine D4 receptor ligands | Emerging Cross-Sectional Technologies | 5 | Expired |
| US5858327A | Hydrazino-type N.sub.2 S.sub.2 radionuclide chelating compounds | Physics | 3 | Expired |
| US5725838A | Radiolabeled D4 receptor ligands | Chemistry; Metallurgy | 3 | Expired |
| US5804158A | Sequestered imaging agents | Human Necessities | 2 | Expired |
| US5866544A | Peptide-chelator conjugates | Human Necessities | 1 | Expired |
| US6334996B1 | Chelators that predominantely form a single stereoisomeric species upon coordination to a metal center | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.